Valuation Tibet Rhodiola Pharmaceutical Holding Co.

Stocks

End-of-day quote Shanghai S.E. 20/10/2026			5-day change	1st Jan Change
36.40 ^CNY	-0.22%		-1.19%	-14.45%

10-08	Tranche Update on Tibet Rhodiola Pharmaceutical Holding Co.'s Equity Buyback Plan announced on December 18, 2025.	CI
08-13	Tibet Rhodiola Pharmaceutical Holding Co. Reports Earnings Results for the Half Year Ended June 30, 2026	CI

Data adjusted to current consolidation scope

Fiscal Period: December	2020	2021	2022	2023	2024	2025
Market Cap ¹	16,681	12,982	8,906	12,099	11,906	13,715
Change	-	-22.18%	-31.4%	35.86%	-1.59%	15.19%
Enterprise Value (EV) ¹	15,908	12,218	7,462	10,226	9,555	11,106
Change	-	-23.19%	-38.93%	37.05%	-6.56%	16.23%
P/E	39.8x	62.3x	24.1x	15.1x	11.3x	14.6x
PBR	6.48x	4.94x	2.96x	3.62x	3.04x	3.61x
PEG	-	-1.2x	0.3x	0x	0.4x	-1.4x
Capitalization / Revenue	12.1x	6.07x	3.49x	3.86x	4.24x	4.6x
EV / Revenue	11.6x	5.71x	2.92x	3.26x	3.4x	3.72x
EV / EBITDA	32.8x	18.7x	9.85x	9.25x	9.87x	11.1x
EV / EBIT	39.1x	21.3x	10.8x	9.85x	10.7x	12x
EV / FCF	207x	-208x	16.3x	17.5x	19.8x	15.9x
FCF Yield	0.48%	-0.48%	6.14%	5.73%	5.06%	6.28%
Dividend per Share ²	0.3923	0.26	0.5738	1.492	1.957	1.757
Rate of return	0.76%	0.65%	2.08%	3.97%	5.3%	4.13%
EPS ²	1.3	0.6462	1.146	2.485	3.26	2.91
Distribution rate	30.2%	40.2%	50.1%	60%	60%	60.4%
Net sales ¹	1,373	2,139	2,555	3,134	2,807	2,982
EBITDA ¹	485	654.2	757.5	1,105	967.6	1,002
EBIT ¹	407.3	572.7	688.3	1,039	893.4	924.7
Net income ¹	418.1	208.9	369.8	800.9	1,051	937.9
Net Debt ¹	-773.1	-763.6	-1,444	-1,873	-2,351	-2,609
Reference price ²	51.75	40.28	27.63	37.54	36.94	42.55
Nbr of stocks (in thousands)	322,319	322,319	322,319	322,319	322,319	322,319
Announcement Date	11/03/21	11/03/22	10/03/23	26/03/24	14/03/25	12/03/26

¹CNY in Million²CNY

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
TIBET RHODIOLA PHARMACEUTICAL HOLDING CO.	-	-	-	-	1.74B
ELI LILLY AND COMPANY	35.75x	12.79x	26.94x	0.55%	1,106B
JOHNSON & JOHNSON	37.14x	6.26x	17.62x	2.1%	612B
ABBVIE INC.	36.08x	8.31x	17.14x	2.43%	500B
ROCHE HOLDING AG	20.6x	4.98x	12.38x	2.63%	367B
MERCK & CO., INC.	104.7x	5.86x	25.15x	2.37%	354B
NOVARTIS AG	21.05x	5.51x	13.55x	2.9%	286B
ASTRAZENECA PLC	21.56x	4.37x	12.5x	2.02%	256B
AMGEN INC.	26.98x	6.96x	12.46x	2.37%	230B
GILEAD SCIENCES, INC.	-44.72x	6.87x	26.59x	2.15%	190B
Average	28.79x	6.88x	18.26x	2.17%	390.19B
Weighted average by Cap.	34.40x	8.11x	19.89x	1.85%